Hong Kong’s Hospital Authority pledges to reduce ethics review period for clinical trials from 6 months to 30 days starting next year
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
New arrangement expected to come into effect in first quarter of 2024, according to authority director Michael Wong.